{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:00:03Z","timestamp":1780678803678,"version":"3.54.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,17]]},"abstract":"<jats:p>\n                    This study aims to analyze the influencing factors of N-terminal pro-B-type natriuretic peptide (NT-proBNP) expression levels in patients with unstable angina pectoris (UAP) using a logistic regression model, establish a prediction model with internal validation, and propose corresponding intervention strategies. A retrospective analysis was conducted on the clinical data of 100 UAP patients admitted to our hospital from November 2021 to October 2023. Patients were randomly divided into a training set (n\u2005=\u200580) and a validation set (n\u2005=\u200520) at a ratio of 8:2. The training set was further divided into an low NT-proBNP group (n\u2005=\u200540) and a high NT-proBNP group (n\u2005=\u200540) based on serum NT-proBNP levels at admission. Differences in baseline and clinical data between the 2 groups were compared. Variables with significant differences in univariate analysis were included in the logistic regression model to identify influencing factors of NT-proBNP expression levels in UAP patients. A nomogram prediction model was constructed. The predictive value of the model was evaluated using the receiver operating characteristic curve, calibration curve, and decision curve, and corresponding intervention strategies were formulated. There were no significant differences in baseline data between the training and validation sets (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&gt;\u2005.05). In the training set, age, history of myocardial infarction, left ventricular ejection fraction (LVEF), New York Heart Association (NYHA) classification, and serum creatinine showed statistically significant differences between the observation and high NT-proBNP groups (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). The odds ratio values for age, history of myocardial infarction, LVEF, NYHA, and serum creatinine were 1.175 (95% confidence interval [CI]: 1.096\u20131.248), 1.244 (95% CI: 1.185\u20131.460), 0.085 (95% CI: 0.074\u20130.096), 13.183 (95% CI: 2.824\u201361.532), and 1.118 (95% CI: 1.015\u20131.183), respectively. The nomogram model was internally validated using validation set data. The area under the receiver operating characteristic curve area under the curve for the training and validation sets was 0.866 (0.789\u20130.944) and 0.876 (0.801\u20130.951). The model showed high net benefit within the threshold range, demonstrating good applicability. Conclusion Age, history of myocardial infarction, LVEF, NYHA classification, and serum creatinine level are influencing factors of NT-proBNP levels in UAP patients.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000047459","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:02:07Z","timestamp":1776434527000},"page":"e47459","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Logistic regression analysis of factors influencing NT-proBNP expression levels in patients with unstable angina pectoris and intervention strategies"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2899-7447","authenticated-orcid":false,"given":"Zheng","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Emergency Internal Medicine, Bozhou People\u2019s Hospital, Bozhou City, Anhui Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260605","first-page":"36","article-title":"A brief report on utility of N-terminal pro-B-type natriuretic peptide(NT-proBNP)in screening patients at risk of atrial fibrillation and stroke.","volume":"1","author":"Kumar","year":"2024","journal-title":"Demo J"},{"key":"R2-20260605","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1164\/rccm.201109-1745CI","article-title":"Unstable angina and non-ST elevation myocardial infarction.","volume":"185","author":"Braunwald","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"R3-20260605","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/01.CIR.102.1.118","article-title":"A classification of unstable angina revisited.","volume":"102","author":"Hamm","year":"2000","journal-title":"Circulation"},{"key":"R4-20260605","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ahj.2006.10.004","article-title":"Global registry of acute coronary events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome.","volume":"153","author":"Tang","year":"2007","journal-title":"Am Heart J"},{"key":"R5-20260605","doi-asserted-by":"crossref","first-page":"e25621","DOI":"10.1097\/MD.0000000000025621","article-title":"A study of the sequential treatment of acute heart failure with sacubitril\/valsartan by recombinant human brain natriuretic peptide: a randomized controlled trial.","volume":"100","author":"Pang","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"R6-20260605","doi-asserted-by":"crossref","first-page":"901990","DOI":"10.3389\/fcvm.2022.901990","article-title":"Copeptin as a diagnostic and prognostic biomarker in cardiovascular diseases.","volume":"9","author":"Mu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R7-20260605","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12872-022-02654-1","article-title":"Association of serum sclerostin and osteoprotegerin levels with the presence,severity and prognosis in patients with acute myocardial infarction.","volume":"22","author":"Shui","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"R8-20260605","doi-asserted-by":"crossref","first-page":"115181","DOI":"10.1016\/j.ab.2023.115181","article-title":"Copeptin:up-to-date diagnostic and prognostic role highlight.","volume":"673","author":"Abdelmageed","year":"2023","journal-title":"Anal Biochem"},{"key":"R9-20260605","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00392-008-0728-8","article-title":"Determinants of plasma NT-pro-BNP levels in patients with atrial fibrillation and preserved left ventricular ejection fraction.","volume":"98","author":"Letsas","year":"2009","journal-title":"Clin Res Cardiol"},{"key":"R10-20260605","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3904\/kjim.2005.20.1.26","article-title":"Correlation between levels of N-terminal pro-B-type natriuretic peptide and degrees of heart failure.","volume":"20","author":"Song","year":"2005","journal-title":"Korean J Intern Med"},{"key":"R11-20260605","first-page":"e344","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"key":"R12-20260605","doi-asserted-by":"crossref","first-page":"15","DOI":"10.7754\/Clin.Lab.2019.190513","article-title":"Relationship of red cell volume distribution width and N-terminal pro-brain natriuretic peptide with severity and prognosis of patients with acute coronary syndrome receiving percutaneous coronary intervention.","volume":"66","author":"Pan","year":"2020","journal-title":"Clin Lab"},{"key":"R13-20260605","first-page":"191","article-title":"Hypoxia regulates the natriuretic peptide system.","volume":"3","author":"Arjamaa","year":"2011","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"R14-20260605","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1152\/japplphysiol.01082.2007","article-title":"NT-pro-BNP during hypoglycemia and hypoxemia in normal subjects: impact of renin-angiotensin system activity.","volume":"104","author":"Due-Andersen","year":"2008","journal-title":"J Appl Physiol (1985)"},{"key":"R15-20260605","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.ehj.2004.06.017","article-title":"Natriuretic peptides in unstable coronary artery disease.","volume":"25","author":"Jernberg","year":"2004","journal-title":"Eur Heart J"},{"key":"R16-20260605","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.hrtlng.2021.07.007","article-title":"Association of N-terminal pro-brain natriuretic peptide level with adverse outcomes in patients with acute myocardial infarction:a meta-analysis.","volume":"50","author":"Shen","year":"2021","journal-title":"Heart Lung"},{"key":"R17-20260605","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1002\/ehf2.14542","article-title":"Relationship of atrial fibrillation and N terminal pro brain natriuretic peptide in heart failure patients.","volume":"10","author":"Nasab Mehrabi","year":"2023","journal-title":"ESC Heart Fail"},{"key":"R18-20260605","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/heart.89.7.745","article-title":"The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population.","volume":"89","author":"Raymond","year":"2003","journal-title":"Heart"},{"key":"R19-20260605","doi-asserted-by":"crossref","first-page":"e009427","DOI":"10.1161\/CIRCHEARTFAILURE.121.009427","article-title":"Reference ranges for NT-proBNP (N-terminal pro-B-type natriuretic peptide) and risk factors for higher NT-proBNP concentrations in a large general population cohort.","volume":"15","author":"Welsh","year":"2022","journal-title":"Circ Heart Fail"},{"key":"R20-20260605","doi-asserted-by":"crossref","first-page":"e010259","DOI":"10.1161\/CIRCHEARTFAILURE.122.010259","article-title":"Prognostic importance of NT-proBNP (N-terminal Pro-B-type natriuretic peptide) following high-risk myocardial infarction in the PARADISE-MI trial.","volume":"16","author":"Jering","year":"2023","journal-title":"Circ Heart Fail"},{"key":"R21-20260605","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0019-4832(12)60091-1","article-title":"Correlation between NT proBNP and left ventricular ejection fraction in elderly patients presenting to emergency department with dyspnoea.","volume":"64","author":"Belagavi","year":"2012","journal-title":"Indian Heart J"},{"key":"R22-20260605","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/eci.12234","article-title":"Kidney function crucially affects B-type natriuretic peptide (BNP), N-terminal proBNP and their relationship.","volume":"44","author":"Takase","year":"2014","journal-title":"Eur J Clin Invest"},{"key":"R23-20260605","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ahj.2023.05.014","article-title":"Associations of N-terminal pro-B-type natriuretic peptide, estimated glomerular filtration rate, and mortality in US adults.","volume":"264","author":"Ozkan","year":"2023","journal-title":"Am Heart J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047459","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:01:37Z","timestamp":1780675297000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":23,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047459","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"2025-11-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}